AbuRahma Ali F, Srivastava Mohit, Stone Patrick A, Chong Benny, Jackson Will, Dean L Scott, Mousa Albeir Y
Department of Surgery, West Virginia University, Charleston, WVa.
Department of Surgery, West Virginia University, Charleston, WVa.
J Vasc Surg. 2015 Mar;61(3):675-82. doi: 10.1016/j.jvs.2014.10.019. Epub 2014 Dec 9.
Several studies have reported mixed results after carotid endarterectomy (CEA) in patients with chronic renal insufficiency (CRI), and we previously reported the perioperative outcome in patients with CRI by use of serum creatinine (Cr) level and glomerular filtration rate (GFR). However, only a few of these studies used GFR by the Modification of Diet in Renal Disease equation in their analysis of long-term outcome.
During the study period, 1000 CEAs (926 patients) were analyzed; 940 of these CEAs had Cr levels and 925 had GFR data. Patients were classified into normal (GFR ≥60 mL/min/1.73 m(2) or Cr <1.5 mg/dL), moderate CRI (GFR ≥30-59 or Cr ≥1.5-2.9), and severe CRI (GFR <30 or Cr ≥3).
At a mean follow-up of 34.5 months and a median of 34 months (range, 1-53 months), combined stroke and death rates for Cr levels (867 patients) were 9%, 18%, and 44% for Cr <1.5, ≥1.5 to 2.9, and ≥3 (P = .0001) in contrast to 8%, 14%, and 26% for GFR (854 patients) of >60, ≥30 to 59, and <30, respectively (P = .0003). Combined stroke and death rates for asymptomatic patients were 8%, 17%, and 44% (P = .0001) for patients with Cr levels of <1.5, ≥1.5 to 2.9, and ≥3, respectively, vs 7%, 13%, and 24% for a GFR of ≥60, ≥30 to 59, and <30 (P = .0063). By Kaplan-Meier analysis, stroke-free survival rates at 1 year, 2 years, and 3 years were 97%, 94%, and 92% for Cr <1.5; 92%, 85%, and 81% for Cr ≥1.5 to 2.9; and 56%, 56%, and 56% for Cr ≥3 (P < .0001); vs 98%, 95%, and 93% for a GFR ≥60; 93%, 90%, and 86% for a GFR of ≥30 to 59; and 86%, 77%, and 73% for a GFR <30 (P < .0001). These rates for asymptomatic patients at 1 year, 2 years, and 3 years were 97%, 95%, and 93% for Cr <1.5; 94%, 87%, and 82% for Cr ≥1.5 to 2.9; and 56%, 56%, and 56% for Cr ≥3 (P < .0001); vs 98%, 95%, and 94% for a GFR ≥60; 95%, 91%, and 86% for a GFR of ≥30 to 59; and 84%, 80%, and 75% for a GFR <30 (P = .0026). A univariate regression analysis for asymptomatic patients showed that the hazard ratio (HR) of stroke and death was 6.5 (P = .0003) for a Cr ≥3 and 3.1 for a GFR <30 (P = .0089). A multivariate analysis showed that Cr ≥3 had an HR of stroke and death of 4.7 (P = .008), and GFR <30 had an HR of 2.2 (P = .097).
Patients with severe CRI had higher rates of combined stroke/death. Therefore, CEA for these patients (particularly in asymptomatic patients) must be considered with caution.
多项研究报告了慢性肾功能不全(CRI)患者行颈动脉内膜切除术(CEA)后的结果不一,我们之前曾通过血清肌酐(Cr)水平和肾小球滤过率(GFR)报告了CRI患者的围手术期结局。然而,这些研究中只有少数在分析长期结局时使用了肾脏病膳食改良公式计算的GFR。
在研究期间,对1000例CEA手术(926例患者)进行了分析;其中940例CEA有Cr水平数据,925例有GFR数据。患者被分为正常组(GFR≥60 mL/(min·1.73 m²)或Cr<1.5 mg/dL)、中度CRI组(GFR≥30 - 59或Cr≥1.5 - 2.9)和重度CRI组(GFR<30或Cr≥3)。
平均随访34.5个月,中位数为34个月(范围1 - 53个月),Cr水平组(867例患者)中,Cr<1.5、≥1.5至2.9、≥3时,卒中与死亡率合并为9%、18%和44%(P = 0.0001);相比之下,GFR组(854例患者)中,GFR>60、≥30至59、<30时,卒中与死亡率合并分别为8%、14%和26%(P = 0.0003)。无症状患者的卒中与死亡率合并情况为,Cr水平<1.5、≥1.5至2.9、≥3时分别为8%、17%和44%(P = 0.